Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Answer from: at Academic Institution
All patients with Hgb SS and patients with Hgb SC who have had any significant complications, excluding chronic pain.
Sign in or Register to read more
22690
Related Questions
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
Is there any indication for monitoring for renal medullary carcinoma in patients with sickle cell trait?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
Can anti-cardiolipin or anti-beta-2 glycoprotein antibodies cause prolonged PTT in the absence of a lupus anticoagulant?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
How would you manage a patient with HbSS and severe pulmonary hypertension on home oxygen?
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?